Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Zibert

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Experimental Dermatology|April 13, 2024
Mobile health technologies in an interventional hybrid study on actinic keratosis: Results from an early phase randomized controlled trial investigating the safety and efficacy of a cytosolic phospholipase A2 inhibitor gel in photodamaged skinVinzent Kevin Ortner, Kim Kilov, Alejandro Castillo Mondragón, et al.
BMJ Open|October 5, 2022
The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A<sub>2</sub> inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trialVinzent Kevin Ortner, Berit Johansen, Kim Kilov, et al.
Blood|August 26, 2011
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)Ulrik Ralfkiaer, Peter H Hagedorn, Nannie Bangsgaard, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Experimental Dermatology|April 13, 2024
Mobile health technologies in an interventional hybrid study on actinic keratosis: Results from an early phase randomized controlled trial investigating the safety and efficacy of a cytosolic phospholipase A2 inhibitor gel in photodamaged skinVinzent Kevin Ortner, Kim Kilov, Alejandro Castillo Mondragón, et al.
BMJ Open|October 5, 2022
The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A<sub>2</sub> inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trialVinzent Kevin Ortner, Berit Johansen, Kim Kilov, et al.
Blood|August 26, 2011
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)Ulrik Ralfkiaer, Peter H Hagedorn, Nannie Bangsgaard, et al.
Pageof 3